Group decision‐making is a process wherein multiple individuals interact simultaneously, analyze problems, evaluate the possible available alternatives, characterized by multiple conflicting criteria, and choose suitable alternative solution to the problem. Technique for establishing order preference by similarity to the ideal solution (TOPSIS) is a well‐known method for multiple‐criteria decision‐making. The purpose of this study is to extend the TOPSIS method to solve multicriteria group decision‐making problems equipped with Pythagorean fuzzy data, in which the assessment information on feasible alternatives, provided by the experts, is presented as Pythagorean fuzzy decision matrices having each entry characterized by Pythagorean fuzzy numbers. A revised closeness index is utilized to obtain the ranking of alternatives and to identify the optimal alternative. The developed Pythagorean fuzzy TOPSIS (PF‐TOPSIS) is illustrated by a flow chart. At length, practical examples interpreting the applicability of our proposed PF‐TOPSIS are solved.
The purpose of this research study is to present some new operations, including rejection, symmetric difference, residue product, and maximal product of Pythagorean fuzzy graphs (PFGs), and to explore some of their properties. This research article introduces certain notions, including intuitionistic fuzzy graphs of 3-type (IFGs3T), intuitionistic fuzzy graphs of 4-type (IFGs4T), and intuitionistic fuzzy graphs of n-type (IFGsnT), and proves that every IFG(n−1)T is an IFGnT (for n ≥ 2). Moreover, this study discusses the application of Pythagorean fuzzy graphs in decision making.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.